ArticleAmerican journal of respiratory and critical care medicine2021
Multiomics Analysis Reveals Distinct Immunogenomic Features of Lung Cancer with Ground-Glass Opacity.
Open access · greenAbstract read
In one paragraph
Article in American journal of respiratory and critical care medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 61 papers.
0numbers the graph read from it
0cells of the map it votes in
61citing papers in PubMed
5.7field-weighted citation impact, top 2% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
61 citing papers in PubMed, 90 citations in OpenAlex.
- The impact of tislelizumab immunotherapy on multiple primary lung cancer presenting as ground-glass nodules: preliminary results analysis from a single-arm, phase II trial.Cancer immunology, immunotherapy : CII · 2025Trial
- The activity and immune dynamics of PD-1 inhibition on high-risk pulmonary ground glass opacity lesions: insights from a single-arm, phase II trial.Signal transduction and targeted therapy · 2024Trial
- Immunotherapy for bilateral multiple ground glass opacities: An exploratory study for synchronous multiple primary lung cancer.Frontiers in immunology · 2022Trial
- Decoding Malignant Lung Ground Glass Opacities: A Radiologic-Pathologic Study From Pure to Semi-Solid Lesions.Thoracic cancer · 2026Article
- Innovative approaches for lung cancer screening and interception.Nature reviews. Clinical oncology · 2026Review
- Proposal on incorporating consolidation-to-tumor ratio into the clinical T1 classification in patients with invasive lung adenocarcinoma.Translational lung cancer research · 2026Article
- Distinct metabolic profiles in lung adenocarcinomas presenting as solid or ground-glass opacities.NPJ precision oncology · 2026Article
- Spatial Profiling Reveals Distinct Molecular and Immune Evolution of Mouse Lung Adenocarcinoma Precancers with or Without Carcinogen Exposure.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026Article
- Decoding adaptive immunity: advanced strategies in T and B cell repertoire analysis.Journal of translational medicine · 2026Review
- Liquid biopsy biomarkers for accurate detection of malignant pulmonary nodules: a meta-analytic approach.Discover oncology · 2026Article
- Short-term quantitative CT changes in synchronous ground-glass nodules during immune checkpoint inhibitor therapy in patients with lung cancer.Frontiers in immunology · 2026Article
- Low OLFM1 and BMP6 Expression Predicts Recurrence in Early-Stage Nonsquamous NSCLC with Pure Solid Tumor Appearance.Cancer research communications · 2025Article
- Influencing factors and prediction of growth heterogeneity in solid nodule non-small cell lung cancer based on artificial intelligence: a prospective study.Translational lung cancer research · 2025Article
- Biomarkers via liquid biopsy for distinguishing malignant from benign pulmonary ground-glass nodule.iScience · 2025Article
- Relationships between growth rate and Ki-67 and immune indices in ground-glass nodule-featured lung adenocarcinoma.BMC cancer · 2025Article
- The correlation between EGFR mutation status and clinicopathological characteristics, Ki67 expression and immune cell infiltration in lung adenocarcinoma with different radiological subtypes.World journal of surgical oncology · 2025Article
- Spatial and multiomics analysis of human and mouse lung adenocarcinoma precursors reveals TIM-3 as a putative target for precancer interception.Cancer cell · 2025Article
- Limited effect of antibiotic use on the management of pulmonary ground-glass nodules.Scientific reports · 2025Article
- Multiomics Analysis Reveals Molecular Changes during Early Progression of Precancerous Lesions to Lung Adenocarcinoma in Never-Smokers.Cancer research · 2025Article
- Role of Radiation-related Lung Function Genes in Prognosis and Immune Infiltration of Lung Adenocarcinoma.Combinatorial chemistry & high throughput screening · 2025Article
1 more citing papers are in PubMed but not listed here.
Corrections and comments
- Commented on by
Authors and funding
20 authors at 5 institutions in 3 countries.
Kezhong ChenDepartment of Thoracic Surgery and.
Jing BaiGeneplus-Beijing Institute, Beijing China.
Alexandre ReubenDepartment of Thoracic/Head and Neck Medical Oncology and.
Heng ZhaoDepartment of Thoracic Surgery and.
Guannan KangDepartment of Thoracic Surgery and.
Chunliu ZhangGeneplus-Beijing Institute, Beijing China.
Qingyi QiDepartment of Radiology, Peking University People's Hospital, China.
Yaping XuGeneplus-Beijing Institute, Beijing China.
Shawna HubertDepartment of Thoracic/Head and Neck Medical Oncology and.
Lianpeng ChangGeneplus-Beijing Institute, Beijing China.
Yanfang GuanGeneplus-Beijing Institute, Beijing China.
Lin FengState Key Laboratory of Molecular Oncology, Department of Etiology and Carcinogenesis, Cancer Institute and Hospital, and.
Kai ZhangDepartment of Cancer Prevention, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China.
Kaitai ZhangState Key Laboratory of Molecular Oncology, Department of Etiology and Carcinogenesis, Cancer Institute and Hospital, and.ORCID 0000-0002-9723-6153
Xin YiGeneplus-Beijing Institute, Beijing China.
Xuefeng XiaGeneplus-Beijing Institute, Beijing China.
Shujun ChengState Key Laboratory of Molecular Oncology, Department of Etiology and Carcinogenesis, Cancer Institute and Hospital, and.
Fan YangDepartment of Thoracic Surgery and.
Jianjun ZhangDepartment of Thoracic/Head and Neck Medical Oncology and.ORCID 0000-0001-7872-3477
Jun WangDepartment of Thoracic Surgery and.ORCID 0000-0002-7033-5012
Beijing General Research Institute of Mining and Metallurgy · CNCancer Institute (WIA) · INChinese Academy of Medical Sciences & Peking Union Medical College · CNThe University of Texas MD Anderson Cancer Center · USPeking University · CN
Funding
The molecular and immune evolution in the progression of lung neoplasia to invasive adenocarcinomaR01CA234629 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI ZHANG, JIANJUN · 2019 to 2023
$1.8MNCI NIH HHS R01 CA234629
Abstract
PubMed holds no abstract for this paper.
Indexed as
Adenocarcinoma of LungAdultAgedAged, 80 and overBiomarkers, TumorCohort StudiesFemaleHumansImaging, Three-DimensionalLung NeoplasmsMaleMiddle AgedPrecancerous ConditionsProspective StudiesRetrospective StudiesSolitary Pulmonary NoduleBiomarkers, Tumorcirculating tumor DNAgenomicsground-glass opacityimmune infiltrationT-cell repertoire
Identifiers
What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.